(175568, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175569, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175570, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175571, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175572, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175573, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175574, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175575, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175576, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175577, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175578, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175579, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175580, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175581, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175582, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175583, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175584, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175585, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175586, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175587, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175588, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175589, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175590, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175591, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175592, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175593, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175594, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175595, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175596, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175597, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175598, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175599, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175600, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175601, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175602, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175603, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175604, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175605, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175606, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175607, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175608, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175609, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175610, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175611, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175612, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175613, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175614, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175615, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175616, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175617, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175618, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175619, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175620, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175621, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175622, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175623, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175624, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175625, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175626, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175627, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175628, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175629, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175630, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175631, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175632, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175633, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175634, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175635, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175636, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175637, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175638, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175639, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175640, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175641, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175642, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175643, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175644, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175645, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175646, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175647, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175648, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175649, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175650, 'HP:0033058', 'Decreased circulating complement C7 concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(175651, 'HP:0001063', 'Acrocyanosis', 'MP:0003196', 'calcified skin', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(175652, 'HP:0001063', 'Acrocyanosis', 'MP:0009932', 'skin fibrosis', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(175653, 'HP:0001063', 'Acrocyanosis', 'MP:0001190', 'reddish skin', 0.43902439024390244, 11.083585311854263, 2.2058930806485364, 'UPHENO:0083450', 'abnormally color anatomical entity color'),
(175654, 'HP:0001063', 'Acrocyanosis', 'MP:0001575', 'cyanosis', 0.41304347826086957, 14.491670050491338, 2.4465669423630767, 'UPHENO:0083438', 'abnormally cyan anatomical entity color'),
(175655, 'HP:0031786', 'Cogan lid twitch', 'MP:0012031', 'abnormal b-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175656, 'HP:0031786', 'Cogan lid twitch', 'MP:0012037', 'abnormal b-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175657, 'HP:0031786', 'Cogan lid twitch', 'MP:0012153', 'increased b-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175658, 'HP:0031786', 'Cogan lid twitch', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175659, 'HP:0031786', 'Cogan lid twitch', 'MP:0006147', 'monocular blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175660, 'HP:0031786', 'Cogan lid twitch', 'MP:0012039', 'abnormal b-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175661, 'HP:0031786', 'Cogan lid twitch', 'MP:0020977', 'decreased FO-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175662, 'HP:0031786', 'Cogan lid twitch', 'MP:0002001', 'blindness', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175663, 'HP:0031786', 'Cogan lid twitch', 'MP:0004021', 'abnormal rod electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175664, 'HP:0031786', 'Cogan lid twitch', 'MP:0020961', 'abnormal c-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175665, 'HP:0031786', 'Cogan lid twitch', 'MP:0011832', 'abnormal visual acuity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175666, 'HP:0031786', 'Cogan lid twitch', 'MP:0020976', 'increased FO-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175667, 'HP:0031786', 'Cogan lid twitch', 'MP:0020979', 'decreased FO-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175668, 'HP:0031786', 'Cogan lid twitch', 'MP:0012151', 'increased a-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175669, 'HP:0031786', 'Cogan lid twitch', 'MP:0014179', 'abnormal blood-retina barrier function', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175670, 'HP:0031786', 'Cogan lid twitch', 'MP:0012035', 'abnormal b-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175671, 'HP:0031786', 'Cogan lid twitch', 'MP:0008144', 'nyctalopia', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175672, 'HP:0031786', 'Cogan lid twitch', 'MP:0020974', 'abnormal FO-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175673, 'HP:0031786', 'Cogan lid twitch', 'MP:0020958', 'abnormal c-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175674, 'HP:0031786', 'Cogan lid twitch', 'MP:0002090', 'abnormal vision', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175675, 'HP:0031786', 'Cogan lid twitch', 'MP:0012145', 'increased a-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175676, 'HP:0031786', 'Cogan lid twitch', 'MP:0012040', 'abnormal c-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175677, 'HP:0031786', 'Cogan lid twitch', 'MP:0012152', 'decreased a-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175678, 'HP:0031786', 'Cogan lid twitch', 'MP:0012032', 'abnormal ERG latency', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175679, 'HP:0031786', 'Cogan lid twitch', 'MP:0012150', 'increased b-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175680, 'HP:0031786', 'Cogan lid twitch', 'MP:0001999', 'photosensitivity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175681, 'HP:0031786', 'Cogan lid twitch', 'MP:0014132', 'abnormal tear film physiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175682, 'HP:0031786', 'Cogan lid twitch', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175683, 'HP:0031786', 'Cogan lid twitch', 'MP:0006152', 'tunnel vision', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175684, 'HP:0031786', 'Cogan lid twitch', 'MP:0012144', 'decreased b-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175685, 'HP:0031786', 'Cogan lid twitch', 'MP:0020978', 'abnormal FO-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175686, 'HP:0031786', 'Cogan lid twitch', 'MP:0031497', 'increased visual acuity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175687, 'HP:0031786', 'Cogan lid twitch', 'MP:0003100', 'myopia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175688, 'HP:0031786', 'Cogan lid twitch', 'MP:0005551', 'abnormal eye electrophysiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175689, 'HP:0031786', 'Cogan lid twitch', 'MP:0006149', 'decreased visual acuity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175690, 'HP:0031786', 'Cogan lid twitch', 'MP:0012146', 'increased b-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175691, 'HP:0031786', 'Cogan lid twitch', 'MP:0006251', 'eyelid apraxia', 0.4594594594594595, 13.944182255188847, 2.5311630610399747, 'UPHENO:0078742', 'abnormality of eyelid physiology'),
(175692, 'HP:0031786', 'Cogan lid twitch', 'MP:0003011', 'delayed dark adaptation', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175693, 'HP:0031786', 'Cogan lid twitch', 'MP:0001389', 'abnormal eye movement', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175694, 'HP:0031786', 'Cogan lid twitch', 'MP:0013145', 'eye discharge', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175695, 'HP:0031786', 'Cogan lid twitch', 'MP:0014157', 'alacrima', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175696, 'HP:0031786', 'Cogan lid twitch', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175697, 'HP:0031786', 'Cogan lid twitch', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175698, 'HP:0031786', 'Cogan lid twitch', 'MP:0012034', 'abnormal a-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175699, 'HP:0031786', 'Cogan lid twitch', 'MP:0006153', 'hypermetropia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175700, 'HP:0031786', 'Cogan lid twitch', 'MP:0008145', 'hemeralopia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175701, 'HP:0031786', 'Cogan lid twitch', 'MP:0020959', 'decreased c-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175702, 'HP:0031786', 'Cogan lid twitch', 'MP:0006145', 'legal blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175703, 'HP:0031786', 'Cogan lid twitch', 'MP:0006150', 'double vision', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175704, 'HP:0031786', 'Cogan lid twitch', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4722222222222222, 9.175301480945878, 2.081533390289742, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(175705, 'HP:0031786', 'Cogan lid twitch', 'MP:0012148', 'decreased a-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175706, 'HP:0031786', 'Cogan lid twitch', 'MP:0005258', 'ocular hypertension', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175707, 'HP:0031786', 'Cogan lid twitch', 'MP:0012143', 'decreased a-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175708, 'HP:0031786', 'Cogan lid twitch', 'MP:0004022', 'abnormal cone electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175709, 'HP:0031786', 'Cogan lid twitch', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175710, 'HP:0031786', 'Cogan lid twitch', 'MP:0012147', 'increased a-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175711, 'HP:0031786', 'Cogan lid twitch', 'MP:0012036', 'abnormal a-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175712, 'HP:0031786', 'Cogan lid twitch', 'MP:0012030', 'abnormal a-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175713, 'HP:0031786', 'Cogan lid twitch', 'MP:0020962', 'increased c-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175714, 'HP:0031786', 'Cogan lid twitch', 'MP:0020963', 'decreased c-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175715, 'HP:0031786', 'Cogan lid twitch', 'MP:0012149', 'decreased b-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175716, 'HP:0031786', 'Cogan lid twitch', 'MP:0012033', 'abnormal ERG implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175717, 'HP:0031786', 'Cogan lid twitch', 'MP:0006148', 'binocular blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175718, 'HP:0031786', 'Cogan lid twitch', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(175719, 'HP:0031786', 'Cogan lid twitch', 'MP:0020218', 'abnormal tear production', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175720, 'HP:0031786', 'Cogan lid twitch', 'MP:0020860', 'abnormal cornea physiology', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175721, 'HP:0031786', 'Cogan lid twitch', 'MP:0006190', 'retina ischemia', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175722, 'HP:0031786', 'Cogan lid twitch', 'MP:0020975', 'abnormal FO-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175723, 'HP:0031786', 'Cogan lid twitch', 'MP:0020439', 'absent b-wave', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175724, 'HP:0031786', 'Cogan lid twitch', 'MP:0013468', 'chromodacryorrhea', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175725, 'HP:0031786', 'Cogan lid twitch', 'MP:0010749', 'absent visual evoked potential', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175726, 'HP:0031786', 'Cogan lid twitch', 'MP:0003859', 'abnormal Harderian gland physiology', 0.425, 9.175301480945878, 1.9747159617023402, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(175727, 'HP:0031786', 'Cogan lid twitch', 'MP:0020960', 'increased c-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175728, 'HP:0031786', 'Cogan lid twitch', 'MP:0020219', 'increased tear production', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175729, 'HP:0031786', 'Cogan lid twitch', 'MP:0005260', 'ocular hypotension', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175730, 'HP:0031786', 'Cogan lid twitch', 'MP:0010748', 'abnormal visual evoked potential', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175731, 'HP:0031786', 'Cogan lid twitch', 'MP:0020220', 'decreased tear production', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175732, 'HP:0031786', 'Cogan lid twitch', 'MP:0013476', 'abnormal Harderian gland porphyrin secretion', 0.4146341463414634, 9.175301480945878, 1.950485400349759, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(175733, 'HP:0031786', 'Cogan lid twitch', 'MP:0001337', 'dry eyes', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175734, 'HP:0031786', 'Cogan lid twitch', 'MP:0003101', 'high myopia', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175735, 'HP:0031786', 'Cogan lid twitch', 'MP:0012154', 'decreased b-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175736, 'HP:0031786', 'Cogan lid twitch', 'MP:0005253', 'abnormal eye physiology', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(175737, 'HP:0031786', 'Cogan lid twitch', 'MP:0005257', 'abnormal intraocular pressure', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(175738, 'HP:0031786', 'Cogan lid twitch', 'MP:0020980', 'increased FO-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(175739, 'HP:0031786', 'Cogan lid twitch', 'MP:0012038', 'abnormal a-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(175740, 'HP:0031786', 'Cogan lid twitch', 'MP:0003096', 'increased corneal light-scattering', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(175741, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175742, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175743, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175744, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175745, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175746, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175747, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175748, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175749, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175750, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175751, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175752, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175753, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175754, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175755, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175756, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175757, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003486', 'abnormal channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175758, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175759, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175760, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175761, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003463', 'abnormal single cell response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175762, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175763, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175764, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175765, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175766, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175767, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175768, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175769, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175770, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175771, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175772, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175773, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175774, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175775, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175776, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175777, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175778, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175779, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004513', 'avnosmia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175780, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175781, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175782, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175783, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175784, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175785, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175786, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175787, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175788, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175789, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175790, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175791, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175792, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175793, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175794, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175795, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175796, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175797, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175798, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175799, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175800, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175801, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175802, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175803, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175804, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175805, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175806, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175807, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175808, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175809, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175810, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002922', 'decreased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175811, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175812, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175813, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175814, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175815, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175816, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175817, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175818, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175819, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175820, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175821, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175822, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175823, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175824, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175825, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175826, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175827, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175828, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175829, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175830, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175831, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175832, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175833, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003219', 'increased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175834, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175835, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175836, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175837, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175838, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175839, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175840, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175841, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175842, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175843, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175844, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175845, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175846, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175847, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175848, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175849, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175850, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175851, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175852, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175853, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175854, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175855, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175856, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175857, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175858, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175859, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175860, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175861, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175862, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175863, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175864, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175865, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175866, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175867, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175868, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175869, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175870, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175871, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175872, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175873, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175874, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175875, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175876, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175877, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175878, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175879, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175880, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175881, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175882, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175883, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175884, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175885, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175886, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175887, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175888, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175889, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175890, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175891, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175892, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175893, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175894, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175895, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175896, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175897, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175898, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175899, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175900, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175901, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175902, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175903, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175904, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175905, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175906, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175907, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175908, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175909, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175910, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175911, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175912, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175913, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175914, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175915, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175916, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175917, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175918, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175919, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175920, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175921, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175922, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175923, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175924, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175925, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175926, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175927, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175928, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002826', 'tonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175929, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175930, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175931, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175932, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175933, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175934, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175935, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175936, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175937, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175938, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175939, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175940, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175941, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175942, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175943, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175944, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175945, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175946, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175947, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175948, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175949, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175950, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175951, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175952, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175953, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175954, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175955, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175956, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175957, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175958, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175959, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175960, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175961, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175962, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175963, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175964, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175965, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175966, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175967, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175968, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175969, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175970, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175971, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175972, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175973, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175974, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175975, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175976, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175977, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175978, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175979, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175980, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175981, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175982, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175983, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175984, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175985, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175986, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175987, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175988, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175989, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175990, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175991, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175992, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175993, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175994, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175995, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175996, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(175997, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175998, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(175999, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176000, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176001, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176002, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176003, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176004, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176005, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176006, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176007, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176008, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176009, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176010, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176011, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176012, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176013, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176014, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176015, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176016, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176017, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176018, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176019, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003476', 'decreased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176020, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176021, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176022, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176023, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176024, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176025, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176026, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176027, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176028, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176029, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176030, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176031, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176032, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176033, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176034, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176035, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176036, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176037, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176038, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176039, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176040, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176041, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176042, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176043, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176044, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176045, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176046, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176047, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176048, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176049, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176050, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176051, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176052, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176053, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176054, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176055, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176056, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176057, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176058, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176059, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176060, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176061, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176062, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176063, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176064, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176065, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176066, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176067, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176068, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176069, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176070, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176071, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176072, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176073, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176074, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176075, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176076, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176077, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176078, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176079, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176080, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176081, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176082, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176083, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176084, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176085, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176086, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176087, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176088, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176089, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176090, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176091, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176092, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003202', 'abnormal neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176093, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176094, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003465', 'increased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176095, 'HP:0032670', 'Tonic status epilepticus', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176096, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003485', 'abnormal channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176097, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176098, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176099, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176100, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176101, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176102, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176103, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176104, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176105, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176106, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176107, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176108, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176109, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176110, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176111, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176112, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176113, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176114, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176115, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176116, 'HP:0032670', 'Tonic status epilepticus', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176117, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176118, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176119, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176120, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176121, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176122, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176123, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176124, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176125, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176126, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176127, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176128, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176129, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176130, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176131, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176132, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176133, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176134, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176135, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176136, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176137, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176138, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176139, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176140, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176141, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176142, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176143, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176144, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176145, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176146, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176147, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176148, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176149, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176150, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176151, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176152, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176153, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176154, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176155, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176156, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176157, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176158, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176159, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005403', 'abnormal nerve conduction', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176160, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176161, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176162, 'HP:0032670', 'Tonic status epilepticus', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176163, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176164, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176165, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176166, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176167, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176168, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176169, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176170, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176171, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002914', 'abnormal endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176172, 'HP:0032670', 'Tonic status epilepticus', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176173, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176174, 'HP:0032670', 'Tonic status epilepticus', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176175, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176176, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176177, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176178, 'HP:0032670', 'Tonic status epilepticus', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176179, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176180, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176181, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176182, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176183, 'HP:0032670', 'Tonic status epilepticus', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176184, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176185, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176186, 'HP:0032670', 'Tonic status epilepticus', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176187, 'HP:0032670', 'Tonic status epilepticus', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176188, 'HP:0032670', 'Tonic status epilepticus', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176189, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176190, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176191, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176192, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176193, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003466', 'decreased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176194, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176195, 'HP:0032670', 'Tonic status epilepticus', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176196, 'HP:0032670', 'Tonic status epilepticus', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176197, 'HP:0032670', 'Tonic status epilepticus', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176198, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176199, 'HP:0032670', 'Tonic status epilepticus', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176200, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176201, 'HP:0032670', 'Tonic status epilepticus', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176202, 'HP:0032670', 'Tonic status epilepticus', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176203, 'HP:0032670', 'Tonic status epilepticus', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176204, 'HP:0032670', 'Tonic status epilepticus', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(176205, 'HP:0100650', 'Vaginal neoplasm', 'MP:0001144', 'vagina atresia', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176206, 'HP:0100650', 'Vaginal neoplasm', 'MP:0008978', 'abnormal vagina weight', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176207, 'HP:0100650', 'Vaginal neoplasm', 'MP:0009708', 'vaginal septum', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176208, 'HP:0100650', 'Vaginal neoplasm', 'MP:0009063', 'abnormal oviduct size', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(176209, 'HP:0100650', 'Vaginal neoplasm', 'MP:0008981', 'enlarged vagina', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176210, 'HP:0100650', 'Vaginal neoplasm', 'MP:0008977', 'abnormal vagina size', 0.4375, 11.78271883249473, 2.2704491822580932, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176211, 'HP:0100650', 'Vaginal neoplasm', 'MP:0008983', 'small vagina', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(176212, 'HP:0031886', 'Abnormal LDL cholesterol concentration', 'MP:0011969', 'abnormal circulating triglyceride level', 0.40476190476190477, 9.93472192593978, 2.0052922405532927, 'UPHENO:0051628', 'abnormal blood lipid level'),
(176213, 'HP:0031886', 'Abnormal LDL cholesterol concentration', 'MP:0031206', 'hypolipidemia', 0.4473684210526316, 9.93472192593978, 2.1081937438491365, 'UPHENO:0051628', 'abnormal blood lipid level'),
(176214, 'HP:0031886', 'Abnormal LDL cholesterol concentration', 'MP:0003949', 'abnormal circulating lipid level', 0.4594594594594595, 9.93472192593978, 2.136492912689469, 'UPHENO:0051628', 'abnormal blood lipid level'),
(176215, 'HP:0031886', 'Abnormal LDL cholesterol concentration', 'MP:0001548', 'hyperlipidemia', 0.4473684210526316, 9.93472192593978, 2.1081937438491365, 'UPHENO:0051628', 'abnormal blood lipid level'),
(176216, 'HP:0002152', 'Hyperproteinemia', 'MP:0005553', 'increased circulating creatinine level', 0.41333333333333333, 9.963291078136551, 2.029325087879328, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(176217, 'HP:0002152', 'Hyperproteinemia', 'MP:0008623', 'increased circulating interleukin-3 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176218, 'HP:0002152', 'Hyperproteinemia', 'MP:0008641', 'increased circulating interleukin-1 beta level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(176219, 'HP:0002152', 'Hyperproteinemia', 'MP:0008575', 'increased circulating interferon-beta level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176220, 'HP:0002152', 'Hyperproteinemia', 'MP:0011612', 'increased circulating ghrelin level', 0.4246575342465753, 9.97294124817027, 2.057932127071724, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176221, 'HP:0002152', 'Hyperproteinemia', 'MP:0030758', 'increased circulating histamine level', 0.4246575342465753, 9.97294124817027, 2.057932127071724, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176222, 'HP:0002152', 'Hyperproteinemia', 'MP:0008553', 'increased circulating tumor necrosis factor level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176223, 'HP:0002152', 'Hyperproteinemia', 'MP:0004731', 'increased circulating gastrin level', 0.5428571428571428, 11.397693902282326, 2.4874323200749124, 'UPHENO:0068533', 'increased level of protein in blood'),
(176224, 'HP:0002152', 'Hyperproteinemia', 'MP:0008591', 'increased circulating interleukin-1 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176225, 'HP:0002152', 'Hyperproteinemia', 'MP:0008599', 'increased circulating interleukin-2 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176226, 'HP:0002152', 'Hyperproteinemia', 'MP:0004702', 'increased circulating insulin-like growth factor I level', 0.5277777777777778, 11.397693902282326, 2.452641343437294, 'UPHENO:0068533', 'increased level of protein in blood'),
(176227, 'HP:0002152', 'Hyperproteinemia', 'MP:0008647', 'increased circulating interleukin-12b level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176228, 'HP:0002152', 'Hyperproteinemia', 'MP:0006375', 'increased circulating angiotensinogen level', 0.5405405405405406, 11.397693902282326, 2.4821191798250366, 'UPHENO:0068533', 'increased level of protein in blood'),
(176229, 'HP:0002152', 'Hyperproteinemia', 'MP:0005122', 'increased circulating thyroid-stimulating hormone level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(176230, 'HP:0002152', 'Hyperproteinemia', 'MP:0008577', 'increased circulating interferon-gamma level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176231, 'HP:0002152', 'Hyperproteinemia', 'MP:0002904', 'increased circulating parathyroid hormone level', 0.5428571428571428, 11.397693902282326, 2.4874323200749124, 'UPHENO:0068533', 'increased level of protein in blood'),
(176232, 'HP:0002152', 'Hyperproteinemia', 'MP:0005565', 'increased blood urea nitrogen level', 0.42028985507246375, 9.963291078136551, 2.046330902682844, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(176233, 'HP:0002152', 'Hyperproteinemia', 'MP:0002712', 'increased circulating glucagon level', 0.5352112676056338, 11.397693902282326, 2.4698530728003893, 'UPHENO:0068533', 'increased level of protein in blood'),
(176234, 'HP:0002152', 'Hyperproteinemia', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.5671641791044776, 11.397693902282326, 2.5425112990451124, 'UPHENO:0068533', 'increased level of protein in blood'),
(176235, 'HP:0002152', 'Hyperproteinemia', 'MP:0030760', 'increased circulating dopamine level', 0.41333333333333333, 9.97294124817027, 2.030307624288426, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176236, 'HP:0002152', 'Hyperproteinemia', 'MP:0008821', 'increased blood uric acid level', 0.4142857142857143, 9.963291078136551, 2.031661674822431, 'UPHENO:0068442', 'increased level of nitrogen molecular entity in blood'),
(176237, 'HP:0002152', 'Hyperproteinemia', 'MP:0005568', 'increased circulating total protein level', 0.5074626865671642, 9.97294124817027, 2.249643429251172, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176238, 'HP:0002152', 'Hyperproteinemia', 'MP:0005564', 'increased hemoglobin content', 0.4175824175824176, 11.397693902282326, 2.181622463805191, 'UPHENO:0068533', 'increased level of protein in blood'),
(176239, 'HP:0002152', 'Hyperproteinemia', 'MP:0008611', 'increased circulating interleukin-15 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176240, 'HP:0002152', 'Hyperproteinemia', 'MP:0002968', 'increased circulating alkaline phosphatase level', 0.547945205479452, 11.397693902282326, 2.499062169550407, 'UPHENO:0068533', 'increased level of protein in blood'),
(176241, 'HP:0002152', 'Hyperproteinemia', 'MP:0008638', 'increased circulating interleukin-1 alpha level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(176242, 'HP:0002152', 'Hyperproteinemia', 'MP:0005124', 'increased circulating prolactin level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(176243, 'HP:0002152', 'Hyperproteinemia', 'MP:0008602', 'increased circulating interleukin-4 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176244, 'HP:0002152', 'Hyperproteinemia', 'MP:0008632', 'increased circulating interleukin-16 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176245, 'HP:0002152', 'Hyperproteinemia', 'MP:0002079', 'increased circulating insulin level', 0.5352112676056338, 11.397693902282326, 2.4698530728003893, 'UPHENO:0068533', 'increased level of protein in blood'),
(176246, 'HP:0002152', 'Hyperproteinemia', 'MP:0008635', 'increased circulating interleukin-18 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176247, 'HP:0002152', 'Hyperproteinemia', 'MP:0005343', 'increased circulating aspartate transaminase level', 0.5633802816901409, 11.397693902282326, 2.534015785524198, 'UPHENO:0068533', 'increased level of protein in blood'),
(176248, 'HP:0002152', 'Hyperproteinemia', 'MP:0000332', 'hemoglobinemia', 0.41237113402061853, 11.397693902282326, 2.1679667801200395, 'UPHENO:0068533', 'increased level of protein in blood'),
(176249, 'HP:0002152', 'Hyperproteinemia', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.43661971830985913, 9.97294124817027, 2.086715792458781, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176250, 'HP:0002152', 'Hyperproteinemia', 'MP:0008629', 'increased circulating interleukin-9 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176251, 'HP:0002152', 'Hyperproteinemia', 'MP:0030653', 'increased circulating glutathione level', 0.4074074074074074, 9.97294124817027, 2.0157009049319403, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176252, 'HP:0002152', 'Hyperproteinemia', 'MP:0011285', 'increased circulating erythropoietin level', 0.5135135135135135, 11.397693902282326, 2.419270518506053, 'UPHENO:0068533', 'increased level of protein in blood'),
(176253, 'HP:0002152', 'Hyperproteinemia', 'MP:0011714', 'increased circulating interleukin-8 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176254, 'HP:0002152', 'Hyperproteinemia', 'MP:0008644', 'increased circulating interleukin-12a level', 0.4819277108433735, 11.397693902282326, 2.343686099122576, 'UPHENO:0068533', 'increased level of protein in blood'),
(176255, 'HP:0002152', 'Hyperproteinemia', 'MP:0005669', 'increased circulating leptin level', 0.5428571428571428, 11.397693902282326, 2.4874323200749124, 'UPHENO:0068533', 'increased level of protein in blood'),
(176256, 'HP:0002152', 'Hyperproteinemia', 'MP:0011009', 'increased circulating glutamate dehydrogenase level', 0.5633802816901409, 11.397693902282326, 2.534015785524198, 'UPHENO:0068533', 'increased level of protein in blood'),
(176257, 'HP:0002152', 'Hyperproteinemia', 'MP:0008626', 'increased circulating interleukin-5 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176258, 'HP:0002152', 'Hyperproteinemia', 'MP:0005309', 'increased circulating ammonia level', 0.4225352112676056, 9.97294124817027, 2.052783192949281, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176259, 'HP:0002152', 'Hyperproteinemia', 'MP:0008608', 'increased circulating interleukin-13 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176260, 'HP:0002152', 'Hyperproteinemia', 'MP:0008593', 'increased circulating interleukin-10 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176261, 'HP:0002152', 'Hyperproteinemia', 'MP:0003352', 'increased circulating renin level', 0.5633802816901409, 11.397693902282326, 2.534015785524198, 'UPHENO:0068533', 'increased level of protein in blood'),
(176262, 'HP:0002152', 'Hyperproteinemia', 'MP:0009060', 'increased circulating interleukin-21 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176263, 'HP:0002152', 'Hyperproteinemia', 'MP:0008614', 'increased circulating interleukin-17 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176264, 'HP:0002152', 'Hyperproteinemia', 'MP:0008596', 'increased circulating interleukin-6 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176265, 'HP:0002152', 'Hyperproteinemia', 'MP:0005522', 'increased circulating atrial natriuretic factor', 0.5428571428571428, 11.397693902282326, 2.4874323200749124, 'UPHENO:0068533', 'increased level of protein in blood'),
(176266, 'HP:0002152', 'Hyperproteinemia', 'MP:0008605', 'increased circulating interleukin-7 level', 0.4878048780487805, 11.397693902282326, 2.3579335622617017, 'UPHENO:0068533', 'increased level of protein in blood'),
(176267, 'HP:0002152', 'Hyperproteinemia', 'MP:0030638', 'increased circulating taurine level', 0.4177215189873418, 9.97294124817027, 2.041056630022107, 'UPHENO:0082534', 'increased bodily fluid base level'),
(176268, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176269, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176270, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176271, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176272, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176273, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176274, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176275, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176276, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176277, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176278, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176279, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176280, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176281, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176282, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176283, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176284, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176285, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176286, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176287, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176288, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176289, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176290, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176291, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176292, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176293, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176294, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176295, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176296, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176297, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176298, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176299, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176300, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176301, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176302, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176303, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176304, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176305, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176306, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176307, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176308, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176309, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176310, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176311, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176312, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176313, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176314, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176315, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176316, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176317, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176318, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176319, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176320, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176321, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176322, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176323, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176324, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176325, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176326, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176327, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176328, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176329, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176330, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176331, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176332, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176333, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176334, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176335, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176336, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176337, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176338, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176339, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176340, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176341, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176342, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176343, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176344, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176345, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176346, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176347, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176348, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176349, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176350, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176351, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176352, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176353, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176354, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176355, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176356, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176357, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176358, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176359, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176360, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176361, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176362, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176363, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176364, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176365, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176366, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176367, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176368, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176369, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176370, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176371, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176372, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176373, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176374, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176375, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176376, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176377, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176378, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176379, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176380, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176381, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176382, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176383, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176384, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176385, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176386, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176387, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176388, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176389, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176390, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176391, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176392, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176393, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176394, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176395, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176396, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176397, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176398, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176399, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176400, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176401, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176402, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176403, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176404, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176405, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176406, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176407, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176408, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176409, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176410, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176411, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176412, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176413, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176414, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176415, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176416, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176417, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176418, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176419, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176420, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176421, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176422, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176423, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176424, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176425, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176426, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176427, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176428, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176429, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176430, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176431, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176432, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176433, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176434, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176435, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176436, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176437, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176438, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176439, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176440, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176441, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176442, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176443, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176444, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176445, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176446, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176447, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176448, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176449, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176450, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176451, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176452, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176453, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176454, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176455, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176456, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176457, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176458, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176459, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176460, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176461, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176462, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176463, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176464, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176465, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176466, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176467, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176468, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176469, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176470, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176471, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176472, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176473, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176474, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176475, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176476, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176477, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176478, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176479, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176480, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176481, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176482, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176483, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176484, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176485, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176486, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176487, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176488, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176489, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176490, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176491, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176492, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176493, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176494, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176495, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176496, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176497, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176498, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176499, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176500, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176501, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176502, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176503, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176504, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176505, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176506, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176507, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176508, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176509, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176510, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176511, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176512, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176513, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176514, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176515, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176516, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176517, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176518, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176519, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176520, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176521, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176522, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176523, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176524, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176525, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176526, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176527, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176528, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176529, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176530, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176531, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176532, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176533, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176534, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176535, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176536, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176537, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176538, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176539, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176540, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176541, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176542, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176543, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176544, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176545, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176546, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176547, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176548, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176549, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176550, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176551, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176552, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176553, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176554, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176555, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176556, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176557, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176558, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176559, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176560, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176561, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176562, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176563, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176564, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176565, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176566, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176567, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176568, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176569, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176570, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176571, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176572, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176573, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176574, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176575, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176576, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176577, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176578, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176579, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176580, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176581, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176582, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176583, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176584, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176585, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176586, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176587, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176588, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176589, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176590, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176591, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176592, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176593, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176594, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176595, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176596, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176597, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176598, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176599, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176600, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176601, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176602, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176603, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176604, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176605, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176606, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176607, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176608, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176609, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176610, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176611, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176612, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176613, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176614, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176615, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176616, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176617, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176618, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176619, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176620, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176621, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176622, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176623, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176624, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176625, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176626, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176627, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176628, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176629, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176630, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176631, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176632, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176633, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176634, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176635, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176636, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176637, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176638, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176639, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176640, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176641, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176642, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176643, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176644, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176645, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176646, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176647, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176648, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176649, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176650, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176651, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176652, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176653, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176654, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176655, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176656, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176657, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176658, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176659, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176660, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176661, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176662, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176663, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176664, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176665, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176666, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176667, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176668, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176669, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176670, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176671, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176672, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176673, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176674, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176675, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176676, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176677, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176678, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176679, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176680, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176681, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176682, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176683, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176684, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176685, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176686, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176687, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176688, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176689, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176690, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176691, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176692, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176693, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176694, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176695, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176696, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176697, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176698, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176699, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176700, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176701, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176702, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176703, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176704, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176705, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176706, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176707, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176708, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176709, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176710, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176711, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176712, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176713, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176714, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176715, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176716, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176717, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176718, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176719, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176720, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176721, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176722, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176723, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176724, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176725, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176726, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176727, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176728, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176729, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176730, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176731, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176732, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176733, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176734, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176735, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176736, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176737, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176738, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176739, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176740, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176741, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176742, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176743, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176744, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176745, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176746, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176747, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176748, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176749, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176750, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176751, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176752, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176753, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176754, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176755, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176756, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176757, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176758, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176759, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176760, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176761, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176762, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176763, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176764, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176765, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176766, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176767, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176768, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176769, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176770, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176771, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176772, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176773, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176774, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176775, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176776, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176777, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176778, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176779, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176780, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176781, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176782, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176783, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176784, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176785, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176786, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176787, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176788, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176789, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176790, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176791, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176792, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176793, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176794, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176795, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176796, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176797, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176798, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176799, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176800, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176801, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176802, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176803, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176804, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176805, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176806, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176807, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176808, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176809, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176810, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176811, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176812, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176813, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176814, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176815, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176816, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176817, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176818, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176819, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176820, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176821, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176822, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176823, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176824, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176825, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176826, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176827, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176828, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176829, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176830, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176831, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176832, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176833, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176834, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176835, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176836, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176837, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176838, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176839, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176840, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176841, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176842, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176843, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176844, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176845, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176846, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176847, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176848, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176849, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176850, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176851, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176852, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176853, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176854, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176855, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176856, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176857, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176858, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176859, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176860, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176861, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176862, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176863, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176864, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176865, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176866, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176867, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176868, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176869, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176870, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176871, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176872, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176873, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176874, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176875, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176876, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176877, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176878, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176879, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176880, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176881, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176882, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176883, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176884, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176885, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176886, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176887, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176888, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176889, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176890, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176891, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176892, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176893, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176894, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176895, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176896, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176897, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176898, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176899, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176900, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176901, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176902, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176903, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176904, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176905, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176906, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176907, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176908, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176909, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176910, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176911, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176912, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176913, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176914, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176915, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176916, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176917, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176918, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176919, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176920, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176921, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176922, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176923, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176924, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176925, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176926, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176927, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176928, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176929, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176930, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176931, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176932, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176933, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176934, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176935, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176936, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176937, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176938, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176939, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176940, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176941, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176942, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176943, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176944, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176945, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176946, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176947, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176948, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176949, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176950, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176951, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176952, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176953, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176954, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176955, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176956, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176957, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176958, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176959, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176960, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176961, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176962, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176963, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176964, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176965, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176966, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176967, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176968, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176969, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176970, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176971, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176972, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176973, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176974, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176975, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176976, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176977, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176978, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176979, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176980, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176981, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176982, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176983, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176984, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176985, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176986, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176987, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176988, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176989, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176990, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176991, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176992, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176993, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176994, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176995, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176996, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176997, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(176998, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(176999, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177000, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177001, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177002, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177003, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177004, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177005, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177006, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177007, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177008, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177009, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177010, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177011, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177012, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177013, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177014, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177015, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177016, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177017, 'HP:0033708', 'Anti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(177018, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0030745', 'increased circulating homocitrulline level', 0.41025641025641024, 8.79336607669424, 1.899351152550542, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(177019, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4444444444444444, 8.79336607669424, 1.9769073576556375, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(177020, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0000676', 'abnormal body water content', 0.5, 7.854487866639924, 1.981727512379026, 'UPHENO:0081546', 'abnormal acid independent continuant level'),
(177021, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.42105263157894735, 8.79336607669424, 1.924180326016549, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(177022, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0000683', 'decreased percent water in carcass', 0.4827586206896552, 7.854487866639924, 1.9472600567779133, 'UPHENO:0081546', 'abnormal acid independent continuant level'),
(177023, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0030624', 'abnormal circulating cysteine level', 0.41025641025641024, 8.79336607669424, 1.899351152550542, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(177024, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0013403', 'abnormal circulating lactate level', 0.4117647058823529, 7.2672972650266505, 1.729860260510463, 'UPHENO:0081547', 'abnormal role bodily fluid level'),
(177025, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0000679', 'increased percent water in carcass', 0.4827586206896552, 7.854487866639924, 1.9472600567779133, 'UPHENO:0081546', 'abnormal acid independent continuant level'),
(177026, 'HP:0004360', 'Abnormality of acid-base homeostasis', 'MP:0005311', 'abnormal circulating amino acid level', 0.43243243243243246, 8.79336607669424, 1.9500094055705797, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(177027, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002313', 'abnormal tidal volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177028, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010938', 'decreased total lung capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(177029, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002133', 'abnormal respiratory system physiology', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177030, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010857', 'pulmonary necrosis', 0.4523809523809524, 9.915985363358194, 2.117971412099692, 'UPHENO:0019970', 'abnormal lung morphology'),
(177031, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002314', 'abnormal respiratory mechanics', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177032, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011048', 'decreased lung tissue damping', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177033, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0001958', 'emphysema', 0.425, 9.150450616995217, 1.9720399367718107, 'UPHENO:0086908', 'abnormal lung morphology'),
(177034, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011043', 'abnormal lung elastance', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177035, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177036, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177037, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0031102', 'rhinorrhea', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177038, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0005586', 'decreased tidal volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177039, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002304', 'abnormal total lung capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177040, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002311', 'abnormal inspiratory capacity', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177041, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0031089', 'sneezing', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177042, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0005585', 'increased tidal volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177043, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002308', 'abnormal residual volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177044, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0004782', 'abnormal surfactant physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177045, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002327', 'abnormal respiratory function', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177046, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010753', 'improved mucociliary clearance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177047, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011046', 'abnormal lung tissue damping', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177048, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0001943', 'abnormal respiration', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177049, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010822', 'pneumothorax', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177050, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0031098', 'abnormal sputum production', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177051, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0001942', 'abnormal lung volume', 0.5128205128205128, 9.915985363358194, 2.2550212192256747, 'UPHENO:0019970', 'abnormal lung morphology'),
(177052, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0001947', 'abnormal mucociliary clearance', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177053, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0003426', 'pulmonary interstitial fibrosis', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(177054, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011045', 'decreased lung elastance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177055, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010937', 'increased total lung capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(177056, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0004881', 'abnormal lung size', 0.4722222222222222, 9.915985363358194, 2.1639197406114756, 'UPHENO:0019970', 'abnormal lung morphology'),
(177057, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0001950', 'abnormal respiratory sounds', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177058, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0014274', 'decreased respiration', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177059, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011044', 'increased lung elastance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177060, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0014275', 'increased respiration', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177061, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177062, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0003298', 'choking', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177063, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0003828', 'pulmonary edema', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(177064, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010950', 'abnormal lung hysteresivity', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177065, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002322', 'abnormal respiratory transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177066, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(177067, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002306', 'abnormal functional residual capacity', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177068, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0006050', 'pulmonary fibrosis', 0.4722222222222222, 9.915985363358194, 2.1639197406114756, 'UPHENO:0019970', 'abnormal lung morphology'),
(177069, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002309', 'abnormal vital capacity', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177070, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0003641', 'small lung', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(177071, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011047', 'increased lung tissue damping', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177072, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0005629', 'abnormal lung weight', 0.4358974358974359, 9.915985363358194, 2.079026838278992, 'UPHENO:0019970', 'abnormal lung morphology'),
(177073, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0002337', 'abnormal whole-body plethysmography', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177074, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0031088', 'coughing', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177075, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0010752', 'impaired mucociliary clearance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177076, 'HP:0025178', 'Subpleural interstitial thickening', 'MP:0011163', 'increased wet-to-dry lung weight ratio', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(177077, 'HP:0012055', 'Ciliary body melanoma', 'MP:0005099', 'abnormal ciliary body morphology', 0.4107142857142857, 13.732678149995134, 2.374912018858684, 'UPHENO:0076792', 'abnormal ciliary body morphology'),
(177078, 'HP:0012055', 'Ciliary body melanoma', 'MP:0014164', 'abnormal ciliary process morphology', 0.40350877192982454, 13.732678149995134, 2.3539872760089575, 'UPHENO:0076792', 'abnormal ciliary body morphology'),
(177079, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0003649', 'decreased heart right ventricle size', 0.4418604651162791, 10.533898285880637, 2.1574320837715364, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177080, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0020205', 'abnormal heart right ventricle weight', 0.41304347826086957, 10.533898285880637, 2.08589500877833, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177081, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0000280', 'thin ventricular wall', 0.40476190476190477, 9.39444824277867, 1.950003785876895, 'UPHENO:0086866', 'abnormal cardiac ventricle morphology'),
(177082, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0010577', 'abnormal heart right ventricle size', 0.48717948717948717, 10.533898285880637, 2.2653695426830933, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177083, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0010578', 'abnormal heart left ventricle size', 0.48717948717948717, 10.533898285880637, 2.2653695426830933, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177084, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0005648', 'heart right ventricle degeneration', 0.475, 10.533898285880637, 2.236873193945804, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177085, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0020323', 'abnormal heart apex size', 0.43243243243243246, 8.197756331773574, 1.8828105881997854, 'UPHENO:0015324', 'abnormal anatomical entity morphology in the heart'),
(177086, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0000279', 'ventricular hypoplasia', 0.4222222222222222, 10.533898285880637, 2.1089442721246523, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177087, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0008772', 'increased heart ventricle size', 0.475, 10.533898285880637, 2.236873193945804, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177088, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0010563', 'increased heart right ventricle size', 0.40425531914893614, 10.533898285880637, 2.063585329818253, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177089, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0020204', 'abnormal heart left ventricle weight', 0.41304347826086957, 10.533898285880637, 2.08589500877833, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177090, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0005608', 'cardiac interstitial fibrosis', 0.4166666666666667, 7.506484928906078, 1.768531044033682, 'UPHENO:0076810', 'abnormal heart morphology'),
(177091, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0005406', 'abnormal heart size', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(177092, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0021155', 'abnormal heart left ventricle wall thickness', 0.4146341463414634, 9.39444824277867, 1.9736410584231356, 'UPHENO:0086866', 'abnormal cardiac ventricle morphology'),
(177093, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0010580', 'decreased heart left ventricle size', 0.4418604651162791, 10.533898285880637, 2.1574320837715364, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177094, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0021156', 'abnormal heart right ventricle wall thickness', 0.4146341463414634, 9.39444824277867, 1.9736410584231356, 'UPHENO:0086866', 'abnormal cardiac ventricle morphology'),
(177095, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0003141', 'cardiac fibrosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(177096, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0010579', 'increased heart left ventricle size', 0.40425531914893614, 10.533898285880637, 2.063585329818253, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(177097, 'HP:0200128', 'Biventricular hypertrophy', 'MP:0020135', 'abnormal heart ventricle wall thickness', 0.4594594594594595, 9.39444824277867, 2.0775870887996386, 'UPHENO:0086866', 'abnormal cardiac ventricle morphology'),
(177098, 'HP:0032122', 'Very low visual acuity', 'MP:0010749', 'absent visual evoked potential', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177099, 'HP:0032122', 'Very low visual acuity', 'MP:0014157', 'alacrima', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177100, 'HP:0032122', 'Very low visual acuity', 'MP:0012036', 'abnormal a-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177101, 'HP:0032122', 'Very low visual acuity', 'MP:0012035', 'abnormal b-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177102, 'HP:0032122', 'Very low visual acuity', 'MP:0012034', 'abnormal a-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177103, 'HP:0032122', 'Very low visual acuity', 'MP:0003101', 'high myopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177104, 'HP:0032122', 'Very low visual acuity', 'MP:0020974', 'abnormal FO-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177105, 'HP:0032122', 'Very low visual acuity', 'MP:0003100', 'myopia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177106, 'HP:0032122', 'Very low visual acuity', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177107, 'HP:0032122', 'Very low visual acuity', 'MP:0004022', 'abnormal cone electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177108, 'HP:0032122', 'Very low visual acuity', 'MP:0012030', 'abnormal a-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177109, 'HP:0032122', 'Very low visual acuity', 'MP:0005253', 'abnormal eye physiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177110, 'HP:0032122', 'Very low visual acuity', 'MP:0020218', 'abnormal tear production', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177111, 'HP:0032122', 'Very low visual acuity', 'MP:0020975', 'abnormal FO-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177112, 'HP:0032122', 'Very low visual acuity', 'MP:0020439', 'absent b-wave', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177113, 'HP:0032122', 'Very low visual acuity', 'MP:0006150', 'double vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177114, 'HP:0032122', 'Very low visual acuity', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177115, 'HP:0032122', 'Very low visual acuity', 'MP:0005260', 'ocular hypotension', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177116, 'HP:0032122', 'Very low visual acuity', 'MP:0020219', 'increased tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177117, 'HP:0032122', 'Very low visual acuity', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177118, 'HP:0032122', 'Very low visual acuity', 'MP:0013468', 'chromodacryorrhea', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177119, 'HP:0032122', 'Very low visual acuity', 'MP:0001999', 'photosensitivity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177120, 'HP:0032122', 'Very low visual acuity', 'MP:0011832', 'abnormal visual acuity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177121, 'HP:0032122', 'Very low visual acuity', 'MP:0020220', 'decreased tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177122, 'HP:0032122', 'Very low visual acuity', 'MP:0006153', 'hypermetropia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177123, 'HP:0032122', 'Very low visual acuity', 'MP:0001337', 'dry eyes', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177124, 'HP:0032122', 'Very low visual acuity', 'MP:0020860', 'abnormal cornea physiology', 0.43902439024390244, 8.795504987450572, 1.9650550155155173, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177125, 'HP:0032122', 'Very low visual acuity', 'MP:0003096', 'increased corneal light-scattering', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177126, 'HP:0032122', 'Very low visual acuity', 'MP:0005551', 'abnormal eye electrophysiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177127, 'HP:0032122', 'Very low visual acuity', 'MP:0013145', 'eye discharge', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177128, 'HP:0032122', 'Very low visual acuity', 'MP:0012037', 'abnormal b-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177129, 'HP:0032122', 'Very low visual acuity', 'MP:0005258', 'ocular hypertension', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177130, 'HP:0032122', 'Very low visual acuity', 'MP:0012031', 'abnormal b-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177131, 'HP:0032122', 'Very low visual acuity', 'MP:0012040', 'abnormal c-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177132, 'HP:0032122', 'Very low visual acuity', 'MP:0012033', 'abnormal ERG implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177133, 'HP:0032122', 'Very low visual acuity', 'MP:0003011', 'delayed dark adaptation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177134, 'HP:0032122', 'Very low visual acuity', 'MP:0020958', 'abnormal c-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177135, 'HP:0032122', 'Very low visual acuity', 'MP:0020961', 'abnormal c-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177136, 'HP:0032122', 'Very low visual acuity', 'MP:0020978', 'abnormal FO-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177137, 'HP:0032122', 'Very low visual acuity', 'MP:0012039', 'abnormal b-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177138, 'HP:0032122', 'Very low visual acuity', 'MP:0006149', 'decreased visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177139, 'HP:0032122', 'Very low visual acuity', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177140, 'HP:0032122', 'Very low visual acuity', 'MP:0006190', 'retina ischemia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177141, 'HP:0032122', 'Very low visual acuity', 'MP:0008145', 'hemeralopia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177142, 'HP:0032122', 'Very low visual acuity', 'MP:0006152', 'tunnel vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177143, 'HP:0032122', 'Very low visual acuity', 'MP:0014132', 'abnormal tear film physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177144, 'HP:0032122', 'Very low visual acuity', 'MP:0031497', 'increased visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177145, 'HP:0032122', 'Very low visual acuity', 'MP:0012032', 'abnormal ERG latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177146, 'HP:0032122', 'Very low visual acuity', 'MP:0005257', 'abnormal intraocular pressure', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177147, 'HP:0032122', 'Very low visual acuity', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177148, 'HP:0032122', 'Very low visual acuity', 'MP:0004021', 'abnormal rod electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177149, 'HP:0032122', 'Very low visual acuity', 'MP:0010748', 'abnormal visual evoked potential', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177150, 'HP:0032122', 'Very low visual acuity', 'MP:0002090', 'abnormal vision', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177151, 'HP:0032122', 'Very low visual acuity', 'MP:0012038', 'abnormal a-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(177152, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177153, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011350', 'abnormal proximal convoluted tubule brush border morphology', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177154, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011344', 'abnormal loop of Henle ascending limb thick segment morphology', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177155, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0002135', 'abnormal kidney morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177156, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177157, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177158, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011534', 'granular kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177159, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011289', 'abnormal nephron number', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177160, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177161, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0002703', 'abnormal renal tubule morphology', 0.4864864864864865, 10.047451525800549, 2.2108707313929497, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177162, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177163, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177164, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004755', 'abnormal loop of Henle morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177165, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177166, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177167, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0003881', 'abnormal nephron morphology', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177168, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004756', 'abnormal proximal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177169, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177170, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011402', 'renal cast', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177171, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.45714285714285713, 8.472720947690348, 1.9680558584047614, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(177172, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177173, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011342', 'abnormal loop of Henle ascending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177174, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011331', 'abnormal papillary duct morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177175, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0009860', 'nephrosclerosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177176, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177177, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(177178, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011352', 'proximal convoluted tubule brush border loss', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177179, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177180, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004969', 'pale kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177181, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004757', 'abnormal distal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177182, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177183, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177184, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011351', 'absent proximal convoluted tubule brush border', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177185, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011383', 'abnormal kidney capsule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177186, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0011341', 'abnormal loop of Henle descending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(177187, 'HP:0005583', 'Tubular basement membrane disintegration', 'MP:0000527', 'abnormal kidney development', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(177188, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0011892', 'abnormal circulating transferrin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177189, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177190, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0011888', 'abnormal circulating total protein level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177191, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177192, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0005416', 'abnormal circulating protein level', 0.42105263157894735, 8.001050554100775, 1.8354463738285371, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177193, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177194, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177195, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177196, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0010086', 'abnormal circulating fructosamine level', 0.42424242424242425, 7.3325749822497786, 1.763743004637863, 'UPHENO:0051804', 'abnormal blood chemical entity level'),
(177197, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031075', 'abnormal circulating troponin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177198, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177199, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0011889', 'abnormal circulating ferritin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177200, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177201, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177202, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177203, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0008820', 'abnormal blood uric acid level', 0.43243243243243246, 8.001050554100775, 1.8600843403256369, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177204, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.43243243243243246, 8.001050554100775, 1.8600843403256369, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177205, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0013255', 'abnormal circulating thrombin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177206, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177207, 'HP:0410206', 'Increased circulating nicotinurate level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.41025641025641024, 8.001050554100775, 1.8117622025545863, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(177208, 'HP:0031944', 'Pleural thickening', 'MP:0002311', 'abnormal inspiratory capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177209, 'HP:0031944', 'Pleural thickening', 'MP:0002306', 'abnormal functional residual capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177210, 'HP:0031944', 'Pleural thickening', 'MP:0002308', 'abnormal residual volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177211, 'HP:0031944', 'Pleural thickening', 'MP:0002309', 'abnormal vital capacity', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177212, 'HP:0031944', 'Pleural thickening', 'MP:0005586', 'decreased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(177213, 'HP:0031944', 'Pleural thickening', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177214, 'HP:0031944', 'Pleural thickening', 'MP:0011046', 'abnormal lung tissue damping', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177215, 'HP:0031944', 'Pleural thickening', 'MP:0005585', 'increased tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(177216, 'HP:0031944', 'Pleural thickening', 'MP:0003828', 'pulmonary edema', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(177217, 'HP:0031944', 'Pleural thickening', 'MP:0031102', 'rhinorrhea', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177218, 'HP:0031944', 'Pleural thickening', 'MP:0011043', 'abnormal lung elastance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177219, 'HP:0031944', 'Pleural thickening', 'MP:0003641', 'small lung', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(177220, 'HP:0031944', 'Pleural thickening', 'MP:0004881', 'abnormal lung size', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(177221, 'HP:0031944', 'Pleural thickening', 'MP:0031089', 'sneezing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177222, 'HP:0031944', 'Pleural thickening', 'MP:0031098', 'abnormal sputum production', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177223, 'HP:0031944', 'Pleural thickening', 'MP:0002304', 'abnormal total lung capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(177224, 'HP:0031944', 'Pleural thickening', 'MP:0005629', 'abnormal lung weight', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(177225, 'HP:0031944', 'Pleural thickening', 'MP:0010937', 'increased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(177226, 'HP:0031944', 'Pleural thickening', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177227, 'HP:0031944', 'Pleural thickening', 'MP:0003426', 'pulmonary interstitial fibrosis', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(177228, 'HP:0031944', 'Pleural thickening', 'MP:0001947', 'abnormal mucociliary clearance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177229, 'HP:0031944', 'Pleural thickening', 'MP:0010950', 'abnormal lung hysteresivity', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177230, 'HP:0031944', 'Pleural thickening', 'MP:0001942', 'abnormal lung volume', 0.5, 9.915985363358194, 2.2266550432608767, 'UPHENO:0019970', 'abnormal lung morphology'),
(177231, 'HP:0031944', 'Pleural thickening', 'MP:0011163', 'increased wet-to-dry lung weight ratio', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(177232, 'HP:0031944', 'Pleural thickening', 'MP:0010938', 'decreased total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(177233, 'HP:0031944', 'Pleural thickening', 'MP:0002313', 'abnormal tidal volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(177234, 'HP:0031944', 'Pleural thickening', 'MP:0010857', 'pulmonary necrosis', 0.4418604651162791, 9.915985363358194, 2.093198964441667, 'UPHENO:0019970', 'abnormal lung morphology'),
(177235, 'HP:0031944', 'Pleural thickening', 'MP:0001943', 'abnormal respiration', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177236, 'HP:0031944', 'Pleural thickening', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(177237, 'HP:0031944', 'Pleural thickening', 'MP:0031088', 'coughing', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177238, 'HP:0031944', 'Pleural thickening', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177239, 'HP:0031944', 'Pleural thickening', 'MP:0002133', 'abnormal respiratory system physiology', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177240, 'HP:0031944', 'Pleural thickening', 'MP:0003298', 'choking', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177241, 'HP:0031944', 'Pleural thickening', 'MP:0001958', 'emphysema', 0.4146341463414634, 9.150450616995217, 1.9478422113245026, 'UPHENO:0086908', 'abnormal lung morphology'),
(177242, 'HP:0031944', 'Pleural thickening', 'MP:0006050', 'pulmonary fibrosis', 0.4594594594594595, 9.915985363358194, 2.1344772837995882, 'UPHENO:0019970', 'abnormal lung morphology'),
(177243, 'HP:0031944', 'Pleural thickening', 'MP:0010822', 'pneumothorax', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(177244, 'HP:0012344', 'Morphea', 'MP:0001264', 'increased body size', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177245, 'HP:0012344', 'Morphea', 'MP:0001199', 'thin skin', 0.43902439024390244, 8.594057268470833, 1.9424213631474467, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177246, 'HP:0012344', 'Morphea', 'MP:0001214', 'skin hyperplasia', 0.475, 7.4735768925632104, 1.884130840458678, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177247, 'HP:0012344', 'Morphea', 'MP:0001238', 'thin epidermis stratum spinosum', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177248, 'HP:0012344', 'Morphea', 'MP:0004556', 'enlarged allantois', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177249, 'HP:0012344', 'Morphea', 'MP:0001242', 'hyperkeratosis', 0.4074074074074074, 9.62605573046134, 1.9803349233668712, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177250, 'HP:0012344', 'Morphea', 'MP:0009601', 'epidermis stratum granulosum hyperplasia', 0.4523809523809524, 7.4735768925632104, 1.8387234246482052, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177251, 'HP:0012344', 'Morphea', 'MP:0009613', 'thin epidermis suprabasal layer', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177252, 'HP:0012344', 'Morphea', 'MP:0009612', 'thick epidermis suprabasal layer', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177253, 'HP:0012344', 'Morphea', 'MP:0001200', 'thick skin', 0.5789473684210527, 9.62605573046134, 2.3607159154428103, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177254, 'HP:0012344', 'Morphea', 'MP:0002953', 'thick ventricular wall', 0.4318181818181818, 9.62605573046134, 2.038800108791518, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177255, 'HP:0012344', 'Morphea', 'MP:0000588', 'thick tail', 0.5135135135135135, 9.62605573046134, 2.223310526990347, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177256, 'HP:0012344', 'Morphea', 'MP:0001267', 'enlarged chest', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177257, 'HP:0012344', 'Morphea', 'MP:0009599', 'thick epidermis stratum granulosum', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177258, 'HP:0012344', 'Morphea', 'MP:0010690', 'thick hair follicle outer root sheath', 0.4489795918367347, 9.62605573046134, 2.078918606598198, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177259, 'HP:0012344', 'Morphea', 'MP:0001179', 'thick pulmonary interalveolar septum', 0.40425531914893614, 9.62605573046134, 1.9726591777251068, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177260, 'HP:0012344', 'Morphea', 'MP:0001211', 'wrinkled skin', 0.41025641025641024, 7.4735768925632104, 1.7510233658401706, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177261, 'HP:0012344', 'Morphea', 'MP:0001218', 'thin epidermis', 0.4186046511627907, 8.594057268470833, 1.8967109281441068, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177262, 'HP:0012344', 'Morphea', 'MP:0009598', 'thin epidermis stratum granulosum', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177263, 'HP:0012344', 'Morphea', 'MP:0010973', 'increased periosteum thickness', 0.4634146341463415, 9.62605573046134, 2.1120736480066307, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177264, 'HP:0012344', 'Morphea', 'MP:0030584', 'skin atrophy', 0.425, 7.4735768925632104, 1.7822093533980132, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177265, 'HP:0012344', 'Morphea', 'MP:0013328', 'visceromegaly', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177266, 'HP:0012344', 'Morphea', 'MP:0009714', 'thin epidermis stratum basale', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177267, 'HP:0012344', 'Morphea', 'MP:0001874', 'acanthosis', 0.4418604651162791, 7.4735768925632104, 1.817217147682207, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177268, 'HP:0012344', 'Morphea', 'MP:0031094', 'organomegaly', 0.45714285714285713, 5.9605885577567275, 1.6507090850740274, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177269, 'HP:0012344', 'Morphea', 'MP:0001222', 'epidermal hyperplasia', 0.4634146341463415, 7.4735768925632104, 1.8610117950813025, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177270, 'HP:0012344', 'Morphea', 'MP:0009600', 'hypergranulosis', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177271, 'HP:0012344', 'Morphea', 'MP:0004127', 'thick hypodermis', 0.5128205128205128, 9.62605573046134, 2.221809810972582, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177272, 'HP:0012344', 'Morphea', 'MP:0001245', 'thick dermal layer', 0.5641025641025641, 9.62605573046134, 2.330253788699296, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177273, 'HP:0012344', 'Morphea', 'MP:0000381', 'enlarged hair follicles', 0.4222222222222222, 7.4735768925632104, 1.776375591908054, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177274, 'HP:0012344', 'Morphea', 'MP:0009347', 'increased trabecular bone thickness', 0.4318181818181818, 9.62605573046134, 2.038800108791518, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177275, 'HP:0012344', 'Morphea', 'MP:0009611', 'epidermis stratum spinosum hyperplasia', 0.4523809523809524, 7.4735768925632104, 1.8387234246482052, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177276, 'HP:0012344', 'Morphea', 'MP:0001268', 'barrel chest', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177277, 'HP:0012344', 'Morphea', 'MP:0003196', 'calcified skin', 0.42105263157894735, 7.4735768925632104, 1.7739135316923853, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177278, 'HP:0012344', 'Morphea', 'MP:0012160', 'expanded anterior visceral endoderm', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(177279, 'HP:0012344', 'Morphea', 'MP:0010929', 'increased osteoid thickness', 0.4318181818181818, 9.62605573046134, 2.038800108791518, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177280, 'HP:0012344', 'Morphea', 'MP:0009474', 'thick epidermis stratum spinosum', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177281, 'HP:0012344', 'Morphea', 'MP:0004971', 'dermal hyperplasia', 0.475, 7.4735768925632104, 1.884130840458678, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177282, 'HP:0012344', 'Morphea', 'MP:0009715', 'thick epidermis stratum basale', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177283, 'HP:0012344', 'Morphea', 'MP:0014218', 'increased intestinal mucosa thickness', 0.40425531914893614, 9.62605573046134, 1.9726591777251068, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177284, 'HP:0012344', 'Morphea', 'MP:0009932', 'skin fibrosis', 0.42105263157894735, 7.4735768925632104, 1.7739135316923853, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177285, 'HP:0012344', 'Morphea', 'MP:0010692', 'thick hair follicle inner root sheath', 0.4489795918367347, 9.62605573046134, 2.078918606598198, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177286, 'HP:0012344', 'Morphea', 'MP:0001219', 'thick epidermis', 0.55, 9.62605573046134, 2.3009412534338503, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177287, 'HP:0012344', 'Morphea', 'MP:0001244', 'thin dermal layer', 0.42857142857142855, 8.594057268470833, 1.9191579926554285, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(177288, 'HP:0012344', 'Morphea', 'MP:0004148', 'increased compact bone thickness', 0.4222222222222222, 9.62605573046134, 2.0160195043080176, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177289, 'HP:0012344', 'Morphea', 'MP:0011190', 'thick embryonic epiblast', 0.4418604651162791, 9.62605573046134, 2.0623708353002064, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(177290, 'HP:0006266', 'Small placenta', 'MP:0004257', 'abnormal placenta weight', 0.42, 14.384754846574829, 2.457966036291272, 'UPHENO:0075215', 'abnormal size of placenta'),
(177291, 'HP:0006266', 'Small placenta', 'MP:0004259', 'small placenta', 0.5, 16.19210976863243, 2.8453567235614265, 'UPHENO:0069344', 'decreased size of the placenta'),
(177292, 'HP:0006266', 'Small placenta', 'MP:0004921', 'decreased placenta weight', 0.42857142857142855, 16.19210976863243, 2.6342884456961397, 'UPHENO:0069344', 'decreased size of the placenta'),
(177293, 'HP:0006266', 'Small placenta', 'MP:0004258', 'abnormal placenta size', 0.44680851063829785, 14.384754846574829, 2.5351983924133306, 'UPHENO:0075215', 'abnormal size of placenta'),
(177294, 'HP:0006266', 'Small placenta', 'MP:0004260', 'enlarged placenta', 0.4117647058823529, 14.384754846574829, 2.4337490315539183, 'UPHENO:0075215', 'abnormal size of placenta'),
(177295, 'HP:0006266', 'Small placenta', 'MP:0011521', 'decreased placental labyrinth size', 0.4230769230769231, 11.410750055107773, 2.1971857052408716, 'UPHENO:0087179', 'abnormal placenta morphology'),
(177296, 'HP:0006390', 'Anterior tibial bowing', 'MP:0004371', 'bowed femur', 0.45263157894736844, 12.083585311854263, 2.338677467939909, 'UPHENO:0082475', 'increased curvature anatomical entity in independent continuant'),
(177297, 'HP:0006390', 'Anterior tibial bowing', 'MP:0004372', 'bowed fibula', 0.47368421052631576, 12.083585311854263, 2.3924471924732367, 'UPHENO:0082475', 'increased curvature anatomical entity in independent continuant'),
(177298, 'HP:0006390', 'Anterior tibial bowing', 'MP:0004358', 'bowed tibia', 0.5795454545454546, 15.87018167374507, 3.032736660481673, 'UPHENO:0041136', 'increased curvature tibia'),
(177299, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0003280', 'urinary incontinence', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177300, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0010386', 'abnormal urinary bladder physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177301, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177302, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177303, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031481', 'decreased urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177304, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177305, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0009349', 'increased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177306, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011467', 'decreased urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177307, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011923', 'abnormal bladder urine volume', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177308, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5185185185185185, 8.666588959537362, 2.119855388442396, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177309, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177310, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177311, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177312, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004040', 'abnormal susceptibility to kidney reperfusion injury', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177313, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002893', 'ketoaciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177314, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0010107', 'abnormal renal reabsorption', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177315, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177316, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177317, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177318, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177319, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001756', 'abnormal urination', 0.5, 8.666588959537362, 2.081656667120849, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177320, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031479', 'increased urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177321, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011466', 'increased urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177322, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177323, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001948', 'vesicoureteral reflux', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177324, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011856', 'abnormal glomerular filtration barrier function', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177325, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177326, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011442', 'abnormal renal sodium ion transport', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177327, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177328, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011431', 'increased urine flow rate', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177329, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0013284', 'abnormal renal glomerular filtration', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177330, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177331, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177332, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177333, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011417', 'abnormal renal transport', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177334, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0009350', 'decreased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177335, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177336, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177337, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177338, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0000327', 'hemosiderinuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177339, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011444', 'abnormal renal water homeostasis', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177340, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177341, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177342, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0013305', 'isosthenuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177343, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0003589', 'abnormal ureter physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177344, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177345, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177346, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177347, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177348, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011443', 'abnormal renal water transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177349, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177350, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002136', 'abnormal kidney physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177351, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002988', 'decreased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177352, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177353, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0003621', 'dysuria', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177354, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177355, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0006273', 'abnormal urine organic cation level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177356, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0009645', 'crystalluria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177357, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011421', 'cylindruria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177358, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177359, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011762', 'renal/urinary system inflammation', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177360, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0008055', 'increased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177361, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0014037', 'stranguria', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177362, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0003606', 'kidney failure', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177363, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001760', 'abnormal urine enzyme level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177364, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177365, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031480', 'abnormal urine xanthine level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177366, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177367, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011758', 'renal ischemia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177368, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0030619', 'homogentisic aciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177369, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177370, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177371, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177372, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0010028', 'aciduria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177373, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0013285', 'abnormal renal filtration', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177374, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177375, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031483', 'decreased urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177376, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011900', 'podocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177377, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0009348', 'abnormal urine pH', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177378, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011432', 'decreased urine flow rate', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177379, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0002987', 'abnormal urine osmolality', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177380, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177381, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001761', 'abnormal urination pattern', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177382, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0031484', 'increased urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177383, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011420', 'pyuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177384, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0011418', 'leukocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177385, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(177386, 'HP:0032961', 'Magnesium ammonium phosphate crystalluria', 'MP:0009643', 'abnormal urine homeostasis', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(177387, 'HP:0000980', 'Pallor', 'MP:0009603', 'absent keratohyalin granules', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177388, 'HP:0000980', 'Pallor', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177389, 'HP:0000980', 'Pallor', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(177390, 'HP:0000980', 'Pallor', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177391, 'HP:0000980', 'Pallor', 'MP:0001198', 'tight skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177392, 'HP:0000980', 'Pallor', 'MP:0010285', 'decreased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177393, 'HP:0000980', 'Pallor', 'MP:0002897', 'blotchy skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177394, 'HP:0000980', 'Pallor', 'MP:0002013', 'increased pilomatricoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177395, 'HP:0000980', 'Pallor', 'MP:0000383', 'abnormal hair follicle orientation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177396, 'HP:0000980', 'Pallor', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177397, 'HP:0000980', 'Pallor', 'MP:0003652', 'abnormal skin turgor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177398, 'HP:0000980', 'Pallor', 'MP:0009387', 'abnormal epidermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177399, 'HP:0000980', 'Pallor', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177400, 'HP:0000980', 'Pallor', 'MP:0003653', 'decreased skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177401, 'HP:0000980', 'Pallor', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177402, 'HP:0000980', 'Pallor', 'MP:0001192', 'scaly skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177403, 'HP:0000980', 'Pallor', 'MP:0001201', 'translucent skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177404, 'HP:0000980', 'Pallor', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177405, 'HP:0000980', 'Pallor', 'MP:0009931', 'abnormal skin appearance', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177406, 'HP:0000980', 'Pallor', 'MP:0014273', 'abnormal skin vasculature morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177407, 'HP:0000980', 'Pallor', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177408, 'HP:0000980', 'Pallor', 'MP:0003705', 'abnormal hypodermis morphology', 0.44, 6.509554027552121, 1.692395867438506, 'UPHENO:0002635', 'abnormal integument'),
(177409, 'HP:0000980', 'Pallor', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177410, 'HP:0000980', 'Pallor', 'MP:0009441', 'delayed skin barrier formation', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177411, 'HP:0000980', 'Pallor', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177412, 'HP:0000980', 'Pallor', 'MP:0010016', 'variable depigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177413, 'HP:0000980', 'Pallor', 'MP:0004241', 'acantholysis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177414, 'HP:0000980', 'Pallor', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177415, 'HP:0000980', 'Pallor', 'MP:0001211', 'wrinkled skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177416, 'HP:0000980', 'Pallor', 'MP:0001195', 'flaky skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177417, 'HP:0000980', 'Pallor', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177418, 'HP:0000980', 'Pallor', 'MP:0011239', 'abnormal skin coloration', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177419, 'HP:0000980', 'Pallor', 'MP:0001216', 'abnormal epidermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177420, 'HP:0000980', 'Pallor', 'MP:0013406', 'abnormal epidermal immune compartment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177421, 'HP:0000980', 'Pallor', 'MP:0011515', 'purpura', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177422, 'HP:0000980', 'Pallor', 'MP:0013488', 'increased keratoacanthoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177423, 'HP:0000980', 'Pallor', 'MP:0000400', 'abnormal awl hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(177424, 'HP:0000980', 'Pallor', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177425, 'HP:0000980', 'Pallor', 'MP:0001209', 'spontaneous skin ulceration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177426, 'HP:0000980', 'Pallor', 'MP:0001230', 'epidermal desquamation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177427, 'HP:0000980', 'Pallor', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177428, 'HP:0000980', 'Pallor', 'MP:0008816', 'petechiae', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177429, 'HP:0000980', 'Pallor', 'MP:0001210', 'skin ridges', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177430, 'HP:0000980', 'Pallor', 'MP:0000377', 'abnormal hair follicle morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177431, 'HP:0000980', 'Pallor', 'MP:0001243', 'abnormal dermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177432, 'HP:0000980', 'Pallor', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177433, 'HP:0000980', 'Pallor', 'MP:0008856', 'fetal bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177434, 'HP:0000980', 'Pallor', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177435, 'HP:0000980', 'Pallor', 'MP:0000405', 'abnormal auchene hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(177436, 'HP:0000980', 'Pallor', 'MP:0010300', 'increased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177437, 'HP:0000980', 'Pallor', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177438, 'HP:0000980', 'Pallor', 'MP:0009563', 'dyskeratosis', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177439, 'HP:0000980', 'Pallor', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(177440, 'HP:0000980', 'Pallor', 'MP:0031103', 'skin rash', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177441, 'HP:0000980', 'Pallor', 'MP:0009385', 'abnormal dermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177442, 'HP:0000980', 'Pallor', 'MP:0010206', 'pigment incontinence', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177443, 'HP:0000980', 'Pallor', 'MP:0030923', 'abnormal hair follicle ostium morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177444, 'HP:0000980', 'Pallor', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177445, 'HP:0000980', 'Pallor', 'MP:0009932', 'skin fibrosis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177446, 'HP:0000980', 'Pallor', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177447, 'HP:0000980', 'Pallor', 'MP:0003853', 'dry skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177448, 'HP:0000980', 'Pallor', 'MP:0001193', 'psoriasis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177449, 'HP:0000980', 'Pallor', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177450, 'HP:0000980', 'Pallor', 'MP:0010700', 'hair follicle comedo', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177451, 'HP:0000980', 'Pallor', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177452, 'HP:0000980', 'Pallor', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177453, 'HP:0000980', 'Pallor', 'MP:0009606', 'increased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177454, 'HP:0000980', 'Pallor', 'MP:0008854', 'bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177455, 'HP:0000980', 'Pallor', 'MP:0001197', 'oily skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177456, 'HP:0000980', 'Pallor', 'MP:0012248', 'absent dermatome', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177457, 'HP:0000980', 'Pallor', 'MP:0001189', 'absent skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177458, 'HP:0000980', 'Pallor', 'MP:0001212', 'skin lesions', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177459, 'HP:0000980', 'Pallor', 'MP:0005174', 'abnormal tail pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177460, 'HP:0000980', 'Pallor', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177461, 'HP:0000980', 'Pallor', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177462, 'HP:0000980', 'Pallor', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177463, 'HP:0000980', 'Pallor', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177464, 'HP:0000980', 'Pallor', 'MP:0003940', 'abnormal dermatome morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177465, 'HP:0000980', 'Pallor', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177466, 'HP:0000980', 'Pallor', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(177467, 'HP:0000980', 'Pallor', 'MP:0003941', 'abnormal skin development', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177468, 'HP:0000980', 'Pallor', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177469, 'HP:0000980', 'Pallor', 'MP:0001208', 'blistering', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177470, 'HP:0000980', 'Pallor', 'MP:0001191', 'abnormal skin condition', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177471, 'HP:0000980', 'Pallor', 'MP:0002732', 'increased trichoepithelioma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177472, 'HP:0000980', 'Pallor', 'MP:0009605', 'decreased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177473, 'HP:0000980', 'Pallor', 'MP:0010232', 'delayed skin pigmentation appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177474, 'HP:0000980', 'Pallor', 'MP:0000407', 'abnormal duvet hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(177475, 'HP:0000980', 'Pallor', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177476, 'HP:0000980', 'Pallor', 'MP:0030584', 'skin atrophy', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177477, 'HP:0000980', 'Pallor', 'MP:0001213', 'abnormal skin cell number', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177478, 'HP:0000980', 'Pallor', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177479, 'HP:0000980', 'Pallor', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177480, 'HP:0000980', 'Pallor', 'MP:0002015', 'epithelioid cyst', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177481, 'HP:0000980', 'Pallor', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177482, 'HP:0000980', 'Pallor', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177483, 'HP:0000980', 'Pallor', 'MP:0031309', 'skin cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177484, 'HP:0000980', 'Pallor', 'MP:0000402', 'abnormal zigzag hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(177485, 'HP:0000980', 'Pallor', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177486, 'HP:0000980', 'Pallor', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177487, 'HP:0000980', 'Pallor', 'MP:0009379', 'abnormal foot pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177488, 'HP:0000980', 'Pallor', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177489, 'HP:0000980', 'Pallor', 'MP:0001202', 'skin photosensitivity', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177490, 'HP:0000980', 'Pallor', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4444444444444444, 6.904974582545727, 1.7518212215413265, 'UPHENO:0003811', 'abnormal skin of body'),
(177491, 'HP:0000980', 'Pallor', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177492, 'HP:0000980', 'Pallor', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177493, 'HP:0000980', 'Pallor', 'MP:0001510', 'abnormal coat appearance', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(177494, 'HP:0000980', 'Pallor', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177495, 'HP:0000980', 'Pallor', 'MP:0005421', 'loose skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177496, 'HP:0000980', 'Pallor', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177497, 'HP:0000980', 'Pallor', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177498, 'HP:0000980', 'Pallor', 'MP:0003717', 'pallor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177499, 'HP:0000980', 'Pallor', 'MP:0009827', 'skin detachment', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177500, 'HP:0000980', 'Pallor', 'MP:0003196', 'calcified skin', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177501, 'HP:0000980', 'Pallor', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177502, 'HP:0000980', 'Pallor', 'MP:0009607', 'decreased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177503, 'HP:0000980', 'Pallor', 'MP:0005653', 'phototoxicity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177504, 'HP:0000980', 'Pallor', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177505, 'HP:0000980', 'Pallor', 'MP:0002060', 'abnormal skin morphology', 0.5652173913043478, 7.4735768925632104, 2.055284806280393, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177506, 'HP:0000980', 'Pallor', 'MP:0009604', 'increased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177507, 'HP:0000980', 'Pallor', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177508, 'HP:0000980', 'Pallor', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177509, 'HP:0000980', 'Pallor', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177510, 'HP:0000980', 'Pallor', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177511, 'HP:0000980', 'Pallor', 'MP:0002095', 'abnormal skin pigmentation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177512, 'HP:0000980', 'Pallor', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(177513, 'HP:0000980', 'Pallor', 'MP:0000574', 'abnormal foot pad morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(177514, 'HP:0000980', 'Pallor', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
